TY - JOUR
AB - Breast Cancer Research and Treatment 8: 65-77, 1986 © Martinus Nijhoff Publishers, Boston - Printed in the Netherlands 9TH ANNUAL SAN ANTONIO BREAST CANCER October 31-November 1, 1986 FRIDAY, OCT. 31ST 8:00 - 8:45 8:45 - 9:00 William L. McGuire, M.D., Professor and Chief, Division of Oncology, Department of Medicine, The University of Texas Health Science Center at San Antonio. Charles A. Coltman, Jr., M.D., American Cancer Society Professor of Clinical Oncology, The University of Texas Health Science Center at San Antonio; Medical Director, Cancer Therapy and Research Foundation, San Antonio, Texas. 9:00 - 9:45 PLENARY Molecular Biology of Drug Resistance. Tito Fojo, M.D., Ph.D., Senior Investigator, Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 10:00 - 11:45 GENERAL SESSION 10:00 1. Expression of Tumor-Associated Antigen in the Cytosol of Atypical Hyperplasias of the Breast Defined by Monoclonal Antibody DF3. Ohuchi N, Page DL, Merino M, Thor A, Viglione M, Kufe D, Schlom J. Vanderbilt University, Nashville, TN, and Dana-Farber Cancer Institute, Boston, MA. 10:15 2. Potential Diagnostic Applications of Monoclonal Antibodies to Human Mammary Carcinomas. Mandeville R, Grouix B, Dumas F, Giroux L, Pateisky N. Institut Armand-Frappier and Notre Dame Hospital, Quebec, Canada, and University 
TI - Program
JF - Breast Cancer Research and Treatment
DO - 10.1007/BF01805927
DA - 2005-05-16
UR - https://www.deepdyve.com/lp/springer-journals/program-RC0LZVMB9b
SP - 65
EP - 77
VL - 8
IS - 1
DP - DeepDyve
ER -